Paul Anthony Williams - 08 Jul 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
08 Jul 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 08:29:57 UTC
Previous filing
13 Jun 2023
Next filing
14 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $0 -85 -0.32% $0.000000 26,140 08 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.

Remarks:

This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in it's next proxy statement.